Advent's Life Science Fund Attracts UK Government Backing
This article was originally published in The Pink Sheet Daily
Executive Summary
Advent Venture Partners Raises £70 million for new life sciences fund in Europe.
You may also be interested in...
Proposed U.K. Budget Boost To Benefit Drug Industry
Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.
Proposed U.K. Budget Boost To Benefit Drug Industry
Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.
Cancer Research Technology Ltd.: Biopharma's Gateway to Cancer-Focused Academic Research
Cancer Research Technology - the technology transfer arm of Cancer Research UK, the world's largest charity - has long moved beyond simply commercializing and managing the IP generated by the half billion in research funding provided by Cancer Research UK to five core research institutes across the UK, as well as to researchers at dozens of other universities and organizations. CRT has a growing, 85-strong in-house drug discovery capability which is being expanded with the help of a five-year, £7 million ($11 million) grant from Cancer Research UK - and it's this that lured in AstraZeneca and another industry collaborator, Cephalon.